A global leader in developing innovative cellular medicines, searching for proven labeling consultants, approached Freyr as they required Regulatory support to create and adopt labeling best practices. Their compliance objectives included creating CCDS, UPI and achieving successful BLA approval. At the same time, the client was faced with various process and Regulatory challenges.

Download the proven case to find out how Freyr helped the client achieve core and country labeling objectives by successfully implementing the proven labeling practices quickly.